Colonic disorder
MONDO:0003409Pathological processes in the colon region of the large intestine (intestine, large).
Also known as: colon disease, colon disease or disorder, disease of colon, disease or disorder of colon, disorder of colon
1256 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
New drug combo aims to boost surgery success in colon cancer
Disease control Not yet recruitingThis phase 2 trial is testing whether giving two drugs—Zanzalintinib and Retifanlimab—before surgery can help patients with early-stage colon cancer. The study enrolls adults aged 18 to 80 with a type of colon cancer called pMMR that can be removed surgically. Participants receiv…
Phase: PHASE2 • Sponsor: Northwell Health • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Engineered yeast pill takes on superbug c. diff in first human trial
Disease control Not yet recruitingThis early-stage trial tests an oral capsule containing a genetically modified probiotic yeast designed to neutralize toxins produced by C. diff bacteria. The study first evaluates safety in healthy adults, then in people at risk for recurrent C. diff infection. Participants take…
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Ancient herbs meet modern medicine: can Curcumin-QingDai tame UC?
Disease control Not yet recruitingThis study tests whether adding a combination of curcumin (from turmeric) and QingDai (a traditional Chinese herb) to standard vedolizumab treatment can help people with moderate to severe ulcerative colitis reach remission. About 160 adults will receive either the herbal combo o…
Phase: PHASE4 • Sponsor: Ryan C Ungaro • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Immunotherapy may let some GI cancer patients skip the knife
Disease control Not yet recruitingThis study looks at whether immunotherapy can shrink certain gastrointestinal cancers (like colorectal or stomach cancer) enough that some patients may not need major surgery. People whose tumors have specific genetic features (MSI-H/dMMR or POLE mutation) and who respond well to…
Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Experimental shot takes aim at stomach cancer spread
Disease control Not yet recruitingThis early-stage trial tests a drug called ACM-CpG, which is injected directly into the abdomen to stimulate the immune system against cancer. It includes 24 adults with colorectal or appendix cancer that has spread to the lining of the abdomen or caused fluid buildup. The main g…
Phase: PHASE1 • Sponsor: Brown University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New pill aims to tame severe gut disease
Disease control Not yet recruitingThis study tests an experimental tablet called Hemay005 in 360 Chinese adults with moderate to severe ulcerative colitis, a chronic gut condition. Participants will receive either the drug or a placebo to see if it can bring about remission and improve symptoms over 12 weeks, wit…
Phase: PHASE3 • Sponsor: Ganzhou Hemay Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a natural supplement calm ulcerative colitis?
Disease control Not yet recruitingThis study tests whether a supplement called palmitoylethanolamide (PEA) can help people with mild-to-moderate ulcerative colitis. Researchers will measure changes in disease activity, quality of life, and inflammation markers in 60 participants. The goal is to see if adding PEA …
Phase: NA • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New cocktail aims to make inoperable liver metastases removable
Disease control Not yet recruitingThis study tests whether adding an experimental immunotherapy drug (QL1706) to standard chemotherapy and radiation can shrink liver tumors from colon cancer enough to allow surgery. About 30 adults with colon cancer that has spread only to the liver will receive the combination b…
Phase: PHASE2 • Sponsor: Fujian Medical University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a common antibiotic ease Kids' bowel disease?
Disease control Not yet recruitingThis study tests whether oral vancomycin, an antibiotic, can help children aged 6-15 with inflammatory bowel disease (IBD), especially types linked to liver problems. About 140 kids will either get vancomycin plus standard care or standard care alone for up to a year. Researchers…
Phase: PHASE2 • Sponsor: Tampere University Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New hope for ulcerative colitis patients who failed biologics?
Disease control Not yet recruitingThis study tests an experimental drug called ATH-063 in 120 adults with moderate to severe ulcerative colitis who have not responded to or can no longer use biologic therapies. Participants will receive either the drug or a placebo for 12 weeks to see if it can reduce symptoms an…
Phase: PHASE2 • Sponsor: Athos Therapeutics Inc • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Blood test could personalize chemo breaks for advanced colon cancer
Disease control Not yet recruitingThis phase 3 trial tests whether a blood test that measures tumor DNA (ctDNA) can help doctors decide when to reduce or switch chemotherapy in people with metastatic colorectal cancer. About 408 participants will be randomly assigned to either standard treatment or a strategy whe…
Phase: PHASE3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Real-World study tracks how long patients stick with gut disease drug
Disease control Not yet recruitingThis study observes 35 adults with moderate-to-severe Crohn's disease or ulcerative colitis to see how long they continue taking guselkumab in everyday medical practice. Researchers will track treatment persistence and early symptom relief, like reduced bowel urgency. No experime…
Sponsor: Janssen-Cilag Pharma GmbH • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Organ transplant may offer new hope for rare abdominal cancer patients
Disease control Not yet recruitingThis study tests whether an intestinal or multivisceral transplant can help people with a rare abdominal cancer called pseudomyxoma peritonei (PMP) that cannot be removed by surgery. Twenty participants will receive the transplant and be followed for 12 months to see if they surv…
Phase: PHASE2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New hope for immunotherapy side effects: blood filtering may replace steroids
Disease control Not yet recruitingThis study tests a treatment called extracorporeal photopheresis (ECP) for people with advanced melanoma who develop severe colitis or hepatitis from immunotherapy. ECP filters a patient's blood, treats it with a light-activated drug, and returns it to the body. The trial compare…
Phase: PHASE2 • Sponsor: Therakos LLC • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New combo aims to shrink tough colon cancers before surgery
Disease control Not yet recruitingThis phase II trial tests whether a stronger chemotherapy cocktail (cmFOLFOXIRI) plus an immunotherapy drug (PD-1 inhibitor) works better than standard chemotherapy (mFOLFOX6) when given before surgery for locally advanced colon cancer. About 138 patients with high-risk stage II …
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Could antibiotics replace surgery for Kids' appendicitis?
Disease control Not yet recruitingThis study tests whether treating children with uncomplicated appendicitis using antibiotics alone works as well as surgery. About 724 children aged 5 to 15 will be randomly assigned to receive either antibiotics or an operation. The goal is to see if the antibiotic approach lead…
Phase: PHASE3 • Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New drug cocktail targets cancers missing key gene
Disease control Not yet recruitingThis study tests a new drug combination for people with metastatic solid tumors that lack a gene called MTAP. The drugs, BMS-986504 and pemetrexed, aim to stop cancer cells from growing. The trial will check safety and how well the combo works in 72 participants.
Phase: PHASE1, PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Could a High-Protein, High-Fiber diet tame ulcerative colitis?
Disease control Not yet recruitingThis study will test whether a diet rich in protein and fiber can reduce harmful gas-producing bacteria in the gut of people with ulcerative colitis. Forty adults with mild to moderate disease will eat specially prepared frozen meals for two separate week-long periods. Researcher…
Phase: NA • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Which biologic works best first for ulcerative colitis? major trial aims to find out
Disease control Not yet recruitingThis study compares four different sequences of biologic drugs (infliximab, filgotinib, ustekinumab, and vedolizumab) in 240 adults with moderate to severe ulcerative colitis. The goal is to see which order of treatments works best to achieve and maintain remission without steroi…
Phase: PHASE4 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Chemotherapy fog targets stomach tumors in early trial
Disease control Not yet recruitingThis early-stage trial tests a technique called PIPAC, which turns a chemotherapy drug (mitomycin C) into a mist and sprays it directly onto cancer spread inside the abdomen. It is for people with advanced gastrointestinal cancers that cannot be removed by surgery. The main goal …
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New hope for stomach cancer: experimental drug BHB810 enters human trials
Disease control Not yet recruitingThis study tests a new drug, BHB810, in adults with advanced stomach or gastroesophageal junction cancer that has not responded to standard treatments. The drug is given as an IV infusion every two weeks. The main goals are to check safety and find the best dose, while also seein…
Phase: PHASE1, PHASE2 • Sponsor: BigHat Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Immunotherapy combo aims to shrink colon tumors before surgery
Disease control Not yet recruitingThis study tests whether two immunotherapy drugs, cemiplimab and fianlimab, can safely shrink colon tumors before surgery in people with stage II-III colon cancer that hasn't spread. Participants get two IV doses before surgery, then are followed for up to three years. The goal i…
Phase: PHASE2 • Sponsor: John Strickler, M.D. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Poop pills could help kids with colitis stay healthy
Disease control Not yet recruitingThis study tests whether frozen stool capsules (fecal transplants) can help children aged 8-17 with ulcerative colitis stay in remission after steroid treatment. Participants will receive either capsules or enemas containing healthy donor stool. The main goal is to see if the cap…
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Oxygen chamber therapy put to the test for dozens of diseases
Disease control Not yet recruitingThis study will test hyperbaric oxygen therapy (HBOT) — breathing pure oxygen in a pressurized chamber — for over 30 conditions, including long COVID, Crohn's disease, frostbite, and multiple sclerosis. Researchers will track 100 patients to see if HBOT improves their quality of …
Phase: PHASE4 • Sponsor: Jay C. Buckey Jr. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a single day of antibiotics after appendectomy be enough?
Disease control Not yet recruitingThis trial compares a one-day course of antibiotics after appendix surgery to the standard five-day course in 200 children and adults with uncomplicated appendicitis. The goal is to see if the shorter course prevents infections just as well, while reducing side effects and costs.…
Phase: NA • Sponsor: Ministry of Health and Population, Egypt • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Virus cocktail takes on tough liver tumors
Disease control Not yet recruitingThis phase 2 trial tests whether injecting an oncolytic virus (H101) directly into liver tumors, along with radiation, chemotherapy, targeted therapy, and immunotherapy, can shrink or control colorectal cancer that has spread to the liver and cannot be removed by surgery. The stu…
Phase: PHASE2 • Sponsor: Jun Huang • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Could a heart drug boost colon cancer treatment?
Disease control Not yet recruitingThis study tests if adding a common heart medication (propranolol) to standard chemotherapy and immunotherapy before surgery can improve outcomes for people with a certain type of colon cancer. About 45 adults with stage II or III colon cancer that is mismatch repair proficient (…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Engineered immune cells aim to tame stubborn IBD
Disease control Not yet recruitingThis early-phase study tests a new treatment called ICG318 CAR-T for people with inflammatory bowel disease (IBD) that hasn't improved with standard therapies. The treatment uses a patient's own immune cells, modified in a lab to target and calm the overactive immune response cau…
Phase: PHASE1, PHASE2 • Sponsor: iCell Gene Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug LYNC-101 enters first human trials for ulcerative colitis
Disease control Not yet recruitingThis early-stage trial tests the safety of an experimental drug called LYNC-101 in 50 healthy adults. The drug is given by IV infusion, either as a single dose or multiple doses every 3 weeks. The goal is to see if it is safe and how the body processes it, before testing it in pe…
Phase: PHASE1 • Sponsor: LyncBio Therapeutics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New pill aims to calm Flare-Ups in ulcerative colitis
Disease control Not yet recruitingThis study tests an experimental pill, IPG11406, in 144 adults with moderate to severe ulcerative colitis (UC), a chronic gut condition causing diarrhea and pain. The drug targets immune cells to reduce colon inflammation. Participants receive one of three doses or a placebo for …
Phase: PHASE2 • Sponsor: Nanjing Immunophage Biotech Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Could older UC patients ditch risky meds for a simpler option?
Disease control Not yet recruitingThis study looks at whether older adults (60+) with ulcerative colitis who are in long-term remission can safely stop taking thiopurines (azathioprine or 6-mercaptopurine) and rely only on high-dose mesalazine. Thiopurines carry increased risks of infection and cancer with age, s…
Phase: PHASE4 • Sponsor: Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New oral drug could replace steroids for severe colitis Flare-Ups
Disease control Not yet recruitingThis study tests whether the oral medication upadacitinib can safely treat acute severe ulcerative colitis in hospitalized adults without using steroids. Fifty participants will take upadacitinib daily during their hospital stay and be monitored for up to a year. The goal is to s…
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New pill aims to break the cycle of repeat c. diff infections
Disease control Not yet recruitingThis phase 2 trial tests an oral drug called ibezapolstat in 20 people who have had three or more C. diff infections in the past year. The goal is to see if the drug can cure the current infection and reduce the chance of it coming back. Participants will take the drug twice a da…
Phase: PHASE2 • Sponsor: Acurx Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New hope for tough colon cancer: fruquintinib trial launches in south korea
Disease control Not yet recruitingThis study tests a drug called fruquintinib in 88 adults with advanced colon cancer that has not responded to standard chemotherapies. The goal is to see if adding supportive care to manage side effects can help patients live longer without their cancer growing. Participants will…
Phase: PHASE2 • Sponsor: Korea University Anam Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New drug cocktail aims to shrink liver tumors for surgery
Disease control Not yet recruitingThis phase II trial tests a chemotherapy regimen called FULIRI, combined with either bevacizumab or cetuximab, as a first treatment for colorectal cancer that has spread to the liver. The goal is to shrink the liver tumors enough so they can be surgically removed. The study will …
Phase: PHASE2 • Sponsor: Zhongnan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New hope for ulcerative colitis sufferers: drug trial launches
Disease control Not yet recruitingThis study tests a new drug called SSGJ-627 in 288 adults with moderate to severe ulcerative colitis, a chronic bowel disease. The goal is to see if it safely controls symptoms like bleeding and diarrhea. Participants must have tried other treatments without success.
Phase: PHASE2 • Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Biologic showdown: which IBD drug works best after a year?
Disease control Not yet recruitingThis study will follow 95 adults with moderate-to-severe Crohn's disease or ulcerative colitis in Upper Egypt who are taking one of five biologic drugs: adalimumab, infliximab, ustekinumab, golimumab, or vedolizumab. After one year, researchers will measure how many patients avoi…
Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New combo therapy targets Stomach-Lining cancer in early trial
Disease control Not yet recruitingThis early-phase study tests a new drug combination (PX plus nab-paclitaxel) given directly into the abdomen for people with a type of advanced cancer that has spread to the lining of the belly. The main goal is to find a safe dose and check for side effects. About 22 adults with…
Phase: PHASE1 • Sponsor: Peking University • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Robot arm takes on first appendix surgery in humans
Disease control Not yet recruitingThis early study tests a new robotic surgical system (Revolve) in 3 adults with simple appendicitis who are already scheduled for appendix removal. The robot helps the surgeon work more precisely during minimally invasive surgery. The main goal is to see if the device can safely …
Phase: NA • Sponsor: Unity Health Toronto • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Could a sweetener beat a gut infection? new trial explores xylitol for c. diff in IBD
Disease control Not yet recruitingThis study tests if xylitol, a common sweetener, can safely clear C. difficile bacteria from the gut in people with inflammatory bowel disease (IBD). About 99 adults with mild or inactive IBD will take either a low or high dose of xylitol or a placebo for four weeks. Researchers …
Phase: PHASE1 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Could immunotherapy spare some colon cancer patients from surgery?
Disease control Not yet recruitingThis study tests giving an immunotherapy drug (pembrolizumab) before surgery to people with a specific type of colon cancer (dMMR). The goal is to see if the drug can shrink or eliminate the tumor so some patients may avoid surgery and instead be closely monitored. About 152 adul…
Phase: PHASE2 • Sponsor: Ismail Gögenur • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New cell therapy offers hope for severe IBD patients who have failed other treatments
Disease control Not yet recruitingThis early-stage study tests a new cell therapy called CNK-UT009 in 40 people with severe inflammatory bowel disease (Crohn's or colitis) that hasn't improved with standard treatments. The main goal is to check safety and find the best dose, while also looking at how well it work…
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Could Pre-Surgery chemo boost survival in colon cancer?
Disease control Not yet recruitingThis study compares giving chemotherapy before surgery versus standard surgery-first treatment for people with stage II or III colon cancer that has a high CEA level. About 100 adults aged 18-70 will be randomly assigned to one of two groups. The goal is to see if pre-surgery che…
Phase: NA • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Experimental cell therapy targets Hard-to-Treat cancers
Disease control Not yet recruitingThis early-phase study tests a new cell therapy called KT032 in 24 adults with advanced solid tumors (ovarian, mesothelioma, colon cancer) that have spread to the abdomen and haven't responded to standard treatments. The main goal is to check safety and find the best dose, while …
Phase: EARLY_PHASE1 • Sponsor: Weijia Fang, MD • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Could a daily synbiotic supplement ease ulcerative colitis?
Disease control Not yet recruitingThis pilot study tests a new synbiotic formula (SGR11) in 50 adults with mild-to-moderate ulcerative colitis, a type of inflammatory bowel disease. Participants take the supplement daily for 8 weeks. Researchers will check if symptoms improve and if the supplement is safe, using …
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Stool test strategy aims to prevent UC Flare-Ups
Disease control Not yet recruitingThis study tests whether using stool biomarkers (fecal calprotectin and fecal immunochemical test) to guide treatment adjustments can prevent relapses in people with ulcerative colitis. About 240 adults in remission will be randomly assigned to either biomarker-guided therapy or …
Phase: NA • Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Blood filter device aims to tame severe IBD flares
Disease control Not yet recruitingThis study tests a blood-filtering device called Efferon LPS in 40 adults with Crohn's disease or ulcerative colitis during a flare-up. The device is designed to remove harmful substances from the blood to reduce inflammation. Participants will either receive standard care alone …
Phase: NA • Sponsor: Efferon JSC • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Can acupuncture help tame ulcerative colitis?
Disease control Not yet recruitingThis study tests whether adding acupuncture to the standard drug mesalazine helps people with mild-to-moderate ulcerative colitis achieve and stay in remission. Eighty adults will receive either real acupuncture or sham patches alongside mesalazine for 12 weeks. The goal is to se…
Phase: NA • Sponsor: Qin Yu • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Could a vaccine made from your own tumor stop colon cancer from returning?
Disease control Not yet recruitingThis Phase 3 trial tests a personalized cancer vaccine called OncoVAX for people with Stage II colon cancer. After surgery to remove the tumor, the patient's own cancer cells are used to create a vaccine that trains the immune system to attack any remaining cancer cells. The goal…
Phase: PHASE3 • Sponsor: Vaccinogen Inc • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Keeping patients at the right temperature during surgery may protect their brain
Disease control Not yet recruitingThis study tests whether a step-by-step plan to manage body temperature during a long surgery can lower the chance of postoperative delirium (sudden confusion). The surgery is for a rare abdominal tumor called pseudomyxoma peritonei and involves heated chemotherapy. The trial wil…
Phase: NA • Sponsor: Aerospace Center Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New hope for advanced colon cancer: drug combo trial launches
Disease control Not yet recruitingThis study tests a new drug combination (HLX43 plus HLX07 or serplulimab) in people with advanced or metastatic colorectal cancer that has stopped responding to standard first-line treatment. About 126 participants will receive the experimental therapy to see if it can shrink tum…
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New drug cizutamig tested for tough ulcerative colitis cases
Disease control Not yet recruitingThis early-stage trial will test a new drug called cizutamig in 15 people with moderate to severe ulcerative colitis who haven't improved with other treatments. The main goal is to check if the drug is safe and tolerable. It is not yet recruiting and will be conducted at a single…
Phase: EARLY_PHASE1 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Could antibiotics alone replace drains for diverticulitis abscesses? new pilot study aims to find out
Disease control Not yet recruitingThis pilot study tests whether antibiotics alone are as effective as antibiotics plus percutaneous drainage for treating diverticulitis with a large abscess (4-8 cm). Fifty adults with stable vital signs and no signs of peritonitis will be randomly assigned to one of two groups. …
Phase: NA • Sponsor: Azienda Sanitaria di Firenze • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Old antibiotic, new hope? vancomycin trial for UC and PSC
Disease control Not yet recruitingThis pilot study tests whether the antibiotic vancomycin can safely treat active ulcerative colitis in adults who also have primary sclerosing cholangitis, a liver condition. Fourteen participants will take vancomycin or a placebo for 4 weeks, with an optional 4-week extension. T…
Phase: PHASE2 • Sponsor: McMaster University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New injection after liver ablation aims to stop colorectal cancer in its tracks
Disease control Not yet recruitingThis study tests whether a new drug called IP-001, injected into the liver after standard heat-based tumor destruction, can help prevent colorectal cancer from coming back. About 717 adults with colorectal cancer that has spread only to the liver will be randomly assigned to rece…
Phase: PHASE2, PHASE3 • Sponsor: Immunophotonics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Immune cell therapy takes on IBD: a new hope for tough cases?
Disease control Not yet recruitingThis early-phase study tests a new treatment called RD06-05, a universal CAR-T cell therapy, in 30 adults with moderate-to-severe ulcerative colitis or Crohn's disease who haven't responded to standard treatments. The therapy targets specific immune cells to reduce inflammation i…
Phase: EARLY_PHASE1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Double-Drug attack may tame severe colitis Flare-Ups
Disease control Not yet recruitingThis study looks at adults hospitalized with a severe flare of ulcerative colitis that didn't get better with IV steroids. It compares taking two drugs together (infliximab and tofacitinib) versus taking just one of them. The goal is to see if the combo leads to faster symptom re…
Phase: PHASE2 • Sponsor: Asian Institute of Gastroenterology, India • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Could a sweetener beat a gut infection? early trial tests xylitol for c. diff in IBD patients
Disease control Not yet recruitingThis pilot study tests whether xylitol, a common sugar alcohol, can safely clear C. difficile bacteria from the guts of people with inflammatory bowel disease (IBD). About 69 adults with mild or inactive IBD will take different doses of xylitol for up to 8 weeks. Researchers will…
Phase: EARLY_PHASE1 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New stitch method aims to cut infection risk after appendix removal
Disease control Not yet recruitingThis study will compare two methods of closing the skin after open appendix surgery: standard interrupted stitches versus a continuous stitch under the skin plus a small drain. The goal is to see which method leads to fewer wound infections and better healing. About 100 people ag…
Phase: NA • Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Misted chemotherapy shows promise for Hard-to-Treat abdominal cancers
Disease control Not yet recruitingThis phase 3 trial tests a new method called PIPAC that delivers chemotherapy as a pressurized mist directly into the abdomen during a minimally invasive procedure. It compares this approach plus standard intravenous chemo (FOLFIRI) to standard chemo alone for people with appendi…
Phase: PHASE3 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New drain technique aims to reduce complications after rectal cancer surgery
Disease control Not yet recruitingThis study compares a new drain fixation method (extra-peritoneal tunneling) to the standard method after rectal cancer surgery. About 596 participants will be randomly assigned to one of the two groups. The goal is to see if the new method reduces drain movement and improves the…
Phase: NA • Sponsor: Yeungnam University Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Heat treatment after polyp removal may slash regrowth risk
Disease control Not yet recruitingThis study tests whether adding a heat treatment (thermal ablation) to the standard procedure for removing large colon polyps can lower the chance they grow back. About 752 adults will be randomly assigned to receive either standard removal alone or standard removal plus burning …
Phase: NA • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
No knife needed? new procedure may treat appendicitis without surgery
Disease control Not yet recruitingThis study tests a new, non-surgical treatment called ERAT for mild appendicitis. Instead of removing the appendix, doctors use a flexible tube through the colon to clear the blockage and infection. The trial will compare ERAT to standard laparoscopic surgery in 376 adults to see…
Phase: NA • Sponsor: Changhai Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New hope for IBD patients: can a better antibiotic stop c. diff for good?
Disease control Not yet recruitingThis study compares two antibiotics, fidaxomicin and vancomycin, to see which one is better at clearing C. difficile bacteria from the gut in people with inflammatory bowel disease (IBD). About 60 adults with IBD will take one of the two antibiotics for 10 days and be followed fo…
Phase: PHASE4 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New hope for IBD: IL-23 drugs tested in chinese patients
Disease control Not yet recruitingThis study will follow 178 Chinese adults with Crohn's disease or ulcerative colitis who are starting treatment with IL-23 inhibitors (guselkumab or risankizumab). Researchers will track how well the drugs control symptoms and heal the gut over 52 weeks, as well as any side effec…
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jun 26, 2026 18:58 UTC
-
New foam treatment could help kids with colitis avoid stronger drugs
Disease control Not yet recruitingThis study tests a steroid foam (budesonide) given rectally to children aged 5 to 17 with mild to moderate ulcerative colitis in the lower colon. The goal is to see if it can safely induce remission after 6 weeks of treatment. About 100 children will receive either a low dose, hi…
Phase: PHASE4 • Sponsor: Bausch Health Americas, Inc. • Aim: Disease control
Last updated Jun 26, 2026 18:42 UTC
-
New hope for Crohn's scarring: risankizumab vs ustekinumab in major trial
Disease control Not yet recruitingThis Phase 3 trial will test two drugs, risankizumab and ustekinumab, in 260 adults with fibrostenotic Crohn's disease—a form where the bowel becomes scarred and narrow. The study compares how well each drug prevents further scarring over three years. Participants will receive ei…
Phase: PHASE3 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Jun 26, 2026 18:29 UTC
-
Second chance: drug combo retested for tough colorectal cancer
Disease control Not yet recruitingThis phase 2 trial is testing whether giving the drugs encorafenib and cetuximab again can help people with a specific type of advanced colorectal cancer (BRAF V600E-mutant) whose disease got worse after prior treatment with similar drugs. About 25 participants will receive the d…
Phase: PHASE2 • Sponsor: Vall d'Hebron Institute of Oncology • Aim: Disease control
Last updated Jun 26, 2026 18:05 UTC
-
Surgeons test artificial valve to stop diarrhea after colon cancer removal
Disease control Not yet recruitingThis study tests a new surgical procedure called RISE that rebuilds the ileocecal valve during right colon cancer surgery. Normally, removing this valve can cause diarrhea and malnutrition. The trial will randomly assign 188 patients to either receive the valve reconstruction or …
Phase: NA • Sponsor: Army Medical University, China • Aim: Disease control
Last updated Jun 26, 2026 16:13 UTC
-
New day hospital aims to transform IBD care in a single visit
Disease control Not yet recruitingThis study tests a new type of day hospital for people with inflammatory bowel disease (IBD), like Crohn's disease or ulcerative colitis. In one visit, patients get blood tests, a doctor checkup, education on managing their condition, and optional workshops on diet or fatigue. Th…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 26, 2026 15:48 UTC
-
New combo therapy aims to freeze and burn liver cancer
Disease control Not yet recruitingThis study tests a device that uses both freezing and heating to destroy liver tumors in people with liver cancer or colorectal cancer that has spread to the liver. The goal is to see if this approach improves how long patients live without their cancer growing, and whether it ac…
Phase: NA • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 26, 2026 15:17 UTC
-
New drug cocktail aims to shrink colon tumors before surgery
Disease control Not yet recruitingThis study tests whether a combination of two immunotherapy drugs (iparomlimab and tuvonralimab) plus chemotherapy can shrink tumors before surgery in people with stage III colon cancer that is microsatellite stable (pMMR/MSS). About 21 participants will receive four cycles of th…
Phase: PHASE2 • Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Jun 26, 2026 14:11 UTC
-
Urine test may replace colonoscopy for colitis patients
Diagnosis Not yet recruitingThis study looks at whether a substance in urine, called PGE-MUM, can show if ulcerative colitis is active or in remission. Researchers will collect urine and blood samples from 114 adults with confirmed ulcerative colitis and compare the results with colonoscopy findings. If suc…
Sponsor: Assiut University • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
Dye spray boosts Colonoscopy's hidden polyp detection
Diagnosis Not yet recruitingThis study tests whether spraying a mix of acetic acid and indigo carmine dye during colonoscopy helps doctors find more precancerous polyps (called sessile serrated lesions) in the right side of the colon compared to standard white-light colonoscopy. About 2,689 adults aged 45-8…
Phase: NA • Sponsor: Changhai Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:36 UTC
-
New device may help spot hidden precancerous polyps
Diagnosis Not yet recruitingThis study tests a new device that flattens colon polyps before they are examined under a microscope. The goal is to help doctors better identify sessile serrated lesions, a type of polyp that can lead to colorectal cancer. About 1,156 adults having polyps removed during a colono…
Phase: NA • Sponsor: Changhai Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:36 UTC
-
3D maps could sharpen colon cancer surgery
Diagnosis Not yet recruitingThis study tests whether a 3D computer model, made from a standard CT scan, helps surgeons better plan operations for locally advanced colon cancer. About 168 adults with stage cT3 or cT4 colon cancer will be randomly assigned to have surgery planned with or without the 3D model.…
Phase: NA • Sponsor: Fundació d'investigació Sanitària de les Illes Balears • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
AI-Powered telechecklist could spot appendicitis in kids without In-Person exam
Diagnosis Not yet recruitingThis study tests a simple 10-item checklist that parents can use during a video call to help doctors figure out if a child's belly pain is appendicitis. About 1,500 children aged 3 to 16 with stomach pain will try the checklist with a medical student, then get standard care. The …
Phase: NA • Sponsor: University Hospital, Angers • Aim: Diagnosis
Last updated Jun 27, 2026 11:02 UTC
-
Blood markers may spot colorectal cancer earlier
Diagnosis Not yet recruitingThis study aims to see if measuring two proteins in the blood, Talin-1 and Cripto-1, can help diagnose colorectal cancer. Researchers will compare these levels in 70 newly diagnosed patients and healthy people. The goal is to find a simpler, more accurate way to detect the diseas…
Phase: NA • Sponsor: Assiut University • Aim: Diagnosis
Last updated Jun 27, 2026 09:06 UTC
-
AI reads CT scans to guide colon cancer treatment
Diagnosis Not yet recruitingThis study aims to improve how doctors classify colon tumors by using artificial intelligence (AI) to analyze CT scans. The AI will be trained to tell early-stage tumors from advanced ones and to detect lymph node involvement, which is key for deciding on treatments like chemothe…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jun 27, 2026 09:05 UTC
-
Stool test could spot colon cancer early, study hopes
Diagnosis Not yet recruitingThis study will check how well a non-invasive stool test (quantitative fecal immunochemical test, or qFIT) can detect colorectal cancer and precancerous lesions like adenomas and serrated polyps. Researchers will compare the test results with colonoscopy findings in 150 adults ag…
Sponsor: Sohag University • Aim: Diagnosis
Last updated Jun 27, 2026 09:05 UTC
-
AI boosts colonoscopy accuracy in massive new trial
Diagnosis Not yet recruitingThis study tests whether an artificial intelligence (AI) system can help doctors spot more precancerous polyps and colorectal cancers during colonoscopy compared to standard procedures. Over 3,300 adults scheduled for screening or surveillance will be randomly assigned to AI-assi…
Phase: NA • Sponsor: Zhejiang University • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC
-
AI boosts colonoscopy: finding hidden cancer clues
Diagnosis Not yet recruitingThis study tests whether an artificial intelligence (AI) tool can help doctors spot precancerous growths in the upper part of the colon during a colonoscopy. About 1,200 people with symptoms like belly pain, constipation, or black stools will take part. The goal is to see if usin…
Sponsor: Limian Er • Aim: Diagnosis
Last updated Jun 27, 2026 08:11 UTC
-
AI-Powered test aims to predict best cancer treatment for each patient
Diagnosis Not yet recruitingThis study tests a new platform called xDRIVE that combines drug sensitivity testing and AI to predict which treatments will work best for people with advanced colorectal cancer. The platform will not provide treatment itself but will give doctors a recommendation. The goal is to…
Sponsor: First Ascent Biomedical Inc. • Aim: Diagnosis
Last updated Jun 26, 2026 17:44 UTC
-
SAMe supplement may shield liver from chemo harm
Prevention Not yet recruitingThis study tests whether taking S-adenosylmethionine (SAMe), a natural supplement, can prevent liver injury caused by the chemotherapy drug oxaliplatin. About 30 adults with colorectal cancer that has spread to the liver will take SAMe pills daily for 3-6 months alongside their c…
Phase: PHASE2 • Sponsor: Cedars-Sinai Medical Center • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
New study aims to boost colon cancer screening rates
Prevention Not yet recruitingThis study tests different methods to help people get screened for colorectal cancer. About 2000 adults from community health clinics will receive reminders or extra support to schedule a colonoscopy or stool test. The goal is to see which approach works best to increase screenin…
Phase: NA • Sponsor: Yale University • Aim: Prevention
Last updated Jun 27, 2026 12:26 UTC
-
Bile acid breakthrough: could a Decades-Old pill stop c. diff in its tracks?
Prevention Not yet recruitingThis early-phase trial tests whether adding Ursodeoxycholic Acid (UDCA) to standard antibiotics can prevent Clostridioides difficile (C. diff) infection from returning. About 30 adults with C. diff and risk factors for recurrence will take UDCA three times daily for up to eight w…
Phase: EARLY_PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Prevention
Last updated Jun 27, 2026 12:25 UTC
-
Can kitchen oils beat chemo side effects? new study tests sesame oil and aloe vera
Prevention Not yet recruitingThis study compares three topical treatments—sesame oil, aloe vera gel, and nitroglycerin ointment—against no treatment for preventing phlebitis (vein inflammation) caused by chemotherapy. Researchers will enroll 190 adults with breast or colon cancer receiving specific chemo dru…
Phase: PHASE2 • Sponsor: University of Basrah • Aim: Prevention
Last updated Jun 27, 2026 12:25 UTC
-
New program aims to boost cancer screening in syrian migrant community
Prevention Not yet recruitingThis study tests a culturally tailored educational program to help Syrian migrants in Turkey get screened for breast, cervical, and colorectal cancers. About 30 participants will take part in the program, which uses a questionnaire to measure their motivation and knowledge before…
Phase: NA • Sponsor: Toros University • Aim: Prevention
Last updated Jun 27, 2026 12:23 UTC
-
Old drug, new trick: vancomycin may stop c. diff before it starts
Prevention Not yet recruitingThis study tests whether taking oral vancomycin alongside other antibiotics can prevent Clostridioides difficile infection (C. diff) in people aged 65 and older. Participants are randomly assigned to receive either vancomycin or standard care. The goal is to see if the drug reduc…
Phase: PHASE2, PHASE3 • Sponsor: University of Maryland, Baltimore • Aim: Prevention
Last updated Jun 27, 2026 08:08 UTC
-
Spray instead of clips: new hope for preventing Post-Polypectomy bleeding
Prevention Not yet recruitingThis study tests whether spraying a protective medication (sucralfate) on the wound after removing colon polyps can prevent delayed bleeding better than the standard method of placing clips. The trial will include 160 patients who take blood thinners and have large polyps. Partic…
Phase: PHASE4 • Sponsor: National Cheng-Kung University Hospital • Aim: Prevention
Last updated Jun 27, 2026 08:01 UTC
-
Probiotic drops may stop antibiotic tummy troubles in children
Prevention Not yet recruitingThis study tests whether a probiotic supplement in oral drops can prevent diarrhea in children aged 0-12 who are taking common antibiotics like amoxicillin. One thousand children will receive either the probiotic or a placebo during their antibiotic course, and researchers will t…
Phase: NA • Sponsor: Liaquat University of Medical & Health Sciences • Aim: Prevention
Last updated Jun 27, 2026 07:59 UTC
-
Can a smartphone app help tame IBD symptoms?
Symptom relief Not yet recruitingThis pilot study will test a 24-week digital self-management program designed to help people with inflammatory bowel disease (IBD) manage their symptoms and build long-term healthy habits. The program is accessed via web or mobile device and is used alongside standard care. The s…
Phase: NA • Sponsor: University of Michigan • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Simple pressure check may spare kids from post-surgery sore throat
Symptom relief Not yet recruitingThis study compares two ways of adjusting the air cushion (cuff) on the breathing tube used during general anesthesia in children having laparoscopic appendectomy. One group uses the standard finger-palpation method, while the other uses a pressure sensor to keep the cuff within …
Phase: NA • Sponsor: Ankara Etlik City Hospital • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Can a 2-Hour online class ease IBD pain?
Symptom relief Not yet recruitingThis study tests two online pain education programs for adults with Crohn's disease or ulcerative colitis who have chronic pain. Participants will complete a 2-hour online session and report their pain and quality of life weekly for 8 weeks. The goal is to see if these programs a…
Phase: NA • Sponsor: Cedars-Sinai Medical Center • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Can a smartphone app ease the Gut-Brain struggle for IBD patients?
Symptom relief Not yet recruitingThis study tests a mobile app designed to help Black and Hispanic adults with inflammatory bowel disease (IBD) manage stress and improve their quality of life. The app teaches coping skills, mindfulness, and disease acceptance. Researchers want to see if the app is practical and …
Phase: NA • Sponsor: Montefiore Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Prepping for surgery: could exercise and diet before the knife cut complications?
Symptom relief Not yet recruitingThis study looks at whether a prehabilitation program—including physical therapy, dietary advice, and emotional support—given before major cancer surgery can reduce deaths and serious complications within 30 days after the operation. About 180 adults with cancers of the pancreas,…
Phase: NA • Sponsor: Fox Chase Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Can a special diet tame ulcerative colitis? breath tests may tell
Symptom relief Not yet recruitingThis study tests whether a short liquid diet followed by a low-sulfur eating plan is safe and helpful for people with mild to moderate ulcerative colitis. Researchers will check if this approach improves gut health, lowers inflammation, and eases symptoms. They will also use brea…
Phase: NA • Sponsor: University of British Columbia • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Antibiotics may not be needed for mild diverticulitis, new US trial suggests
Symptom relief Not yet recruitingThis trial tests whether people with mild diverticulitis can be safely treated at home with just pain medicines (ibuprofen and acetaminophen) instead of antibiotics. 556 participants will be randomly assigned to receive either pain medicines alone or pain medicines plus an antibi…
Phase: PHASE4 • Sponsor: Montefiore Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Could a wakefulness drug beat fatigue in IBD patients?
Symptom relief Not yet recruitingThis study tests whether modafinil, a drug used for sleep disorders, can reduce severe fatigue in adults with inactive inflammatory bowel disease (IBD). Sixty participants will take either modafinil or a placebo for 8 weeks, starting at 100 mg daily with possible dose increases. …
Phase: PHASE2, PHASE3 • Sponsor: Radboud University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Remote exercise program aims to boost chemo completion in cancer patients
Symptom relief Not yet recruitingThis study tests whether a home-based exercise program can help people with gastrointestinal or lung cancer handle chemotherapy better. Up to 120 participants will be randomly assigned to either an aerobic and resistance exercise group or a stretching group. All activities are do…
Phase: NA • Sponsor: AdventHealth Translational Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Virtual reality meets AI: could a headset calm IBD anxiety?
Symptom relief Not yet recruitingThis study tests whether an AI-enhanced virtual reality cognitive behavioral therapy (VR/AI CBT) program can reduce anxiety and improve quality of life in people with inflammatory bowel disease (IBD). Seventy-six adults with IBD and moderate-to-severe anxiety will be randomly ass…
Phase: NA • Sponsor: Brennan Spiegel • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Could a special liquid diet tame IBD flares without strong drugs?
Symptom relief Not yet recruitingThis study tests whether a special liquid diet (elemental diet) can help adults with inflammatory bowel disease (IBD) feel better during a flare. The diet provides all nutrients in an easy-to-digest form. Researchers will track symptom changes and inflammation levels in 42 outpat…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Bloating breakthrough? new trial tests antibiotic for gut relief
Symptom relief Not yet recruitingThis study tests whether a 14-day course of the antibiotic rifaximin can reduce bothersome bloating in adults with irritable bowel syndrome, functional constipation, or similar gut disorders. About 78 participants will receive either rifaximin or a placebo, and researchers will m…
Phase: PHASE3 • Sponsor: Mahidol University • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Exercise before and during chemotherapy may boost treatment success
Symptom relief Not yet recruitingThis study tests whether a supervised exercise program, started two weeks before chemotherapy and continued for 16 weeks during treatment, can help adults aged 35 to 65 with breast, lung, or colon cancer tolerate chemotherapy better. The goal is to see if participants can receive…
Phase: NA • Sponsor: University of Vic - Central University of Catalonia • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Exercise may ease IBD symptoms in children, new study hopes to prove
Symptom relief Not yet recruitingThis study explores whether physical activity and fitness can reduce inflammation and improve quality of life in children aged 6 to 17 with Crohn's disease or ulcerative colitis. Researchers will track 100 participants over time and test a 12-week supervised exercise program. The…
Phase: NA • Sponsor: Universidad Complutense de Madrid • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Breath control: a new hope for ulcerative colitis flares?
Symptom relief Not yet recruitingThis study tests whether a 5-week heart rate variability biofeedback program can reduce symptoms in people with ulcerative colitis who are currently having a flare but show no active inflammation. Twenty-three adults will practice daily breathing exercises using a device and be f…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Mind over gut: can meditation tame IBD Flare-Ups?
Symptom relief Not yet recruitingThis study tests whether an 8-week mindfulness-based stress reduction (MBSR) program can lower stress and improve well-being in people with inflammatory bowel disease (IBD). Seventy adults with mild-to-moderate IBD will either take the MBSR course online or watch an educational s…
Phase: NA • Sponsor: Nova Scotia Health Authority • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
One-Day therapy aims to ease IBD and mental health struggles in veterans
Symptom relief Not yet recruitingThis study will test a one-day acceptance and commitment therapy (ACT) program for 50 veterans who have both inflammatory bowel disease (IBD) and a mental health condition like depression, anxiety, or PTSD. The goal is to see if this brief therapy can improve their quality of lif…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Could probiotics tame Chemo's worst symptoms?
Symptom relief Not yet recruitingThis study tests whether taking probiotic supplements can help reduce common chemotherapy side effects like nausea, diarrhea, and loss of appetite in people with stage III colon cancer. Forty adults will be randomly assigned to receive either probiotics or a placebo during their …
Phase: NA • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
New All-in-One monitor aims to make surgery safer for colon cancer patients
Symptom relief Not yet recruitingThis study tests a new device called Medstrom that monitors pain, sedation, and muscle relaxation all in one during laparoscopic colon cancer surgery. Thirty patients will be randomly assigned to either the Medstrom device or standard monitoring. The goal is to see if the device …
Phase: NA • Sponsor: Chinese PLA General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New device aims to make polyp removal easier during colonoscopy
Symptom relief Not yet recruitingThis early study tests a new device that supports the colon wall during polyp removal. It involves 4 people who have a positive stool test and a polyp on the left side of the colon. The main goal is to see if the device can be placed successfully in one try.
Phase: NA • Sponsor: JurongHealth • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
Could a narcolepsy drug beat IBD fatigue?
Symptom relief Not yet recruitingThis study tests whether modafinil, a drug used for narcolepsy, can reduce severe fatigue in people with Crohn's disease or ulcerative colitis. About 70 participants will receive either modafinil or a placebo for 12 weeks. The main goal is to see if a larger trial is possible, bu…
Phase: PHASE2 • Sponsor: Imperial College London • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Which formula works best for Milk-Allergic babies? new study aims to find out
Symptom relief Not yet recruitingThis study tests two special formulas—amino acid formula (AAF) and extensively hydrolyzed formula (eHF)—in 360 infants aged 0-6 months with suspected cow's milk protein allergy. Babies will receive one formula for at least 2 weeks, and doctors will check if symptoms like diarrhea…
Phase: NA • Sponsor: Ruijin Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
New sedative aims to make colonoscopy easier for IBD patients
Symptom relief Not yet recruitingThis study tests whether remimazolam, a newer sedative, works as well as or better than midazolam for colonoscopy in 200 adults with inflammatory bowel disease (Crohn's or colitis). Participants get one of the two drugs plus fentanyl for pain, then rate their satisfaction and are…
Phase: PHASE4 • Sponsor: Humanitas Clinical and Research Center • Aim: Symptom relief
Last updated Jun 26, 2026 14:47 UTC
-
Dutch hospital data reveals hidden patterns in IBD treatment
Knowledge-focused Not yet recruitingThis study looks at medical records from thousands of adults with Crohn's disease or ulcerative colitis treated in Dutch hospitals between 2018 and 2026. Researchers will analyze which treatments patients receive, how often they switch therapies, and how the disease affects other…
Sponsor: LOGEX • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Scientists launch deep dive into IBD to uncover hidden clues
Knowledge-focused Not yet recruitingThis study will follow 100 adults with Crohn's disease, ulcerative colitis, or other IBD, plus their healthy relatives, for up to 3 years. Researchers will collect blood, stool, tissue samples, and imaging to track how immune cells and genetics change over time. The goal is to fi…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Smartwatches could save young lives in ghana by catching danger signs earlier
Knowledge-focused Not yet recruitingThis study will see if using a Garmin smartwatch to continuously track heart rate, breathing rate, and oxygen levels can help doctors spot early warning signs in hospitalized children in Ghana. About 250 children with traumatic injuries or after appendix surgery will wear the wat…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Gut microbes may hold key to diverticular disease
Knowledge-focused Not yet recruitingThis study investigates whether the bacteria living in the gut influence the development of diverticular disease and acute diverticulitis. Researchers will compare the gut microbiota of people with and without these conditions to identify differences and risk factors. The goal is…
Sponsor: Hospital of Navarra • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Acupuncture points may signal hidden disease activity
Knowledge-focused Not yet recruitingThis study investigates whether acupuncture points become tender or more sensitive in people with inflammatory bowel disease (IBD), such as Crohn's disease or ulcerative colitis. Researchers will compare skin temperature, blood flow, and pain sensitivity at specific body points b…
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Study seeks clues to predict who needs closer colon checks after polyp removal
Knowledge-focused Not yet recruitingThis study looks at people who have had certain types of colon polyps (serrated lesions) removed. It aims to find out why some of them later develop new advanced growths in the colon. By tracking 750 adults over time, researchers hope to identify risk factors that could help doct…
Sponsor: Changhai Hospital • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Smartwatches may spot IBD flares before symptoms start
Knowledge-focused Not yet recruitingThis study explores whether changes in heart rate, sleep, and activity measured by a person's own smartwatch can predict flare-ups in inflammatory bowel disease (IBD). Six hundred adults with Crohn's disease or ulcerative colitis who already own a compatible device will participa…
Sponsor: Maastricht University Medical Center • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Blood test and AI team up to outsmart colon cancer recurrence
Knowledge-focused Not yet recruitingThis study explores whether combining artificial intelligence analysis of tumor tissue with special blood tests (liquid biopsy) can more accurately predict if colon cancer will return after surgery. Researchers will follow 400 adults with stage II or III colon cancer for up to fi…
Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Can AI predict heart trouble in IBD patients?
Knowledge-focused Not yet recruitingThis study looks at people with inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease, to better understand their risk of serious heart problems like stroke and heart attack. Researchers will collect information on therapy, disease activity, lifestyle…
Sponsor: IRCCS Policlinico S. Donato • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Study examines which IBD drugs are safer for seniors
Knowledge-focused Not yet recruitingThis study looked at nearly 24,000 older adults (65+) with ulcerative colitis or Crohn's disease to see if certain advanced treatments lead to more infections. Researchers compared patients taking ENTYVIO, TNF-alpha inhibitors, or ustekinumab using Medicare claims data from 2016 …
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Could skipping bowel prep before colon surgery be just as safe?
Knowledge-focused Not yet recruitingThis study looks at whether it's safe to skip mechanical bowel preparation (the drink that cleans out your colon) before colon surgery. Currently, the best practice combines that drink with antibiotics to prevent infections. The trial will compare two groups: one getting the drin…
Phase: NA • Sponsor: Mount Sinai Hospital, Canada • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
New study to measure drug levels in breast milk of moms on TREMFYA
Knowledge-focused Not yet recruitingThis study will measure how much of the drug TREMFYA (guselkumab) passes into breast milk of 10 nursing women who are already taking it for conditions like psoriasis, psoriatic arthritis, ulcerative colitis, or Crohn's disease. Researchers will collect milk samples to estimate th…
Phase: PHASE4 • Sponsor: Janssen Research & Development, LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Could we ditch antibiotics after a burst appendix? new study investigates
Knowledge-focused Not yet recruitingThis pilot study looks at whether it is safe to stop giving antibiotics after surgery for a burst (perforated) appendix. About 100 adults will be randomly assigned to receive either antibiotics or no antibiotics after their operation. The main goal is to see if a larger study is …
Phase: NA • Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Personalized videos may make colonoscopy prep easier for IBD patients
Knowledge-focused Not yet recruitingThis study tests whether watching a short video tailored to their specific type of inflammatory bowel disease (IBD) helps patients better prepare their bowel for a colonoscopy. About 600 adults with ulcerative colitis or Crohn's disease will be randomly assigned to receive either…
Phase: NA • Sponsor: Jie Liang • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New study aims to take the guesswork out of emergency diverticulitis surgery
Knowledge-focused Not yet recruitingThis observational study will collect detailed information from 150 adults undergoing emergency surgery for complicated diverticulitis. Researchers will analyze factors that influence surgeons' decisions to perform either a primary anastomosis (reconnecting the bowel) or a Hartma…
Sponsor: IRCCS San Raffaele Roma • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Glow-in-the-Dark dye could help surgeons spot hidden cancer cells
Knowledge-focused Not yet recruitingThis study is testing whether a green dye called indocyanine green (ICG) can help surgeons see and remove lymph nodes that contain cancer during laparoscopic colon cancer surgery. About 25 adults with colon cancer will receive the dye injected around the tumor and into a vein. Th…
Phase: NA • Sponsor: Tanta University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Scientists map hidden paths of colorectal cancer spread
Knowledge-focused Not yet recruitingThis study looks at where cancer spreads to lymph nodes in people with colon or rectal cancer. Researchers will examine tissue from 1200 patients who had surgery to remove their cancer. The goal is to find patterns that could help doctors better plan treatment in the future.
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
New study tracks polyp return rates to improve Follow-Up care
Knowledge-focused Not yet recruitingThis study looks at how often polyps in the stomach or colon grow back after being removed during a scope procedure. Researchers will follow about 2,000 adults for up to three years to track recurrence and identify risk factors like polyp size, lifestyle, and health history. The …
Sponsor: LanZhou University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
New AI-Powered CT scan could sharpen colon cancer detection
Knowledge-focused Not yet recruitingThis study will test a new way to create CT images for people with colon cancer. The method uses deep learning to make the images clearer. Researchers will compare the quality of these new images to standard ones. The goal is to see if this technique helps doctors see tumors bett…
Sponsor: Philips Clinical & Medical Affairs Global • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Blood test may spare thousands from unnecessary colon surgery
Knowledge-focused Not yet recruitingThis study will collect blood samples from 1,000 people with small colon growths to see if a liquid biopsy can accurately tell benign from malignant lesions and predict cancer spread to lymph nodes. Current methods often lead to unnecessary surgery. The goal is to create a bioban…
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Counseling after positive cancer blood test studied
Knowledge-focused Not yet recruitingThis study looks at how decision counseling affects people who get a positive result on the Shield blood test for colorectal cancer. Researchers want to see if counseling helps reduce confusion and increases the chance of getting a follow-up colonoscopy. About 350 adults aged 45-…
Sponsor: Guardant Health, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New study tracks how a Gut-Joint drug works in real time
Knowledge-focused Not yet recruitingThis study follows 75 adults with Crohn's disease or ulcerative colitis who are starting guselkumab, a drug used for inflammatory bowel disease. Researchers want to see if the drug also helps with joint pain and stiffness linked to spondyloarthritis. Participants will report symp…
Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Could a stretched rectum begin in childhood? new study investigates
Knowledge-focused Not yet recruitingThis study looks at adults with severe constipation and an enlarged rectum (idiopathic megarectum) to see if the problem started in childhood. Researchers will compare 120 participants—some with the condition and some without—by asking about their early-life digestive health and …
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
AI could spot hidden bowel disease years earlier, new study hopes
Knowledge-focused Not yet recruitingThis study will test whether an artificial intelligence (AI) system can help doctors identify inflammatory bowel disease (IBD) earlier and more accurately. Researchers will analyze medical records from 4,500 patients to see how well the AI's suggestions match actual diagnoses. Th…
Sponsor: Taichung Veterans General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Tumor DNA in fluids may predict peritoneal metastasis risk
Knowledge-focused Not yet recruitingThis study looks at whether tumor DNA found in blood or peritoneal fluid can predict the spread of digestive cancers (stomach, colon, pancreas) to the lining of the abdomen. Researchers will follow 300 patients with early-stage tumors to see if those with positive DNA markers are…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
FMT vs antibiotics: which works better Long-Term for c. diff?
Knowledge-focused Not yet recruitingThis study looks at adults who had a C. diff infection and were treated with either a fecal transplant (FMT) or antibiotics alone. Researchers want to see if FMT leads to healthier gut bacteria and fewer health problems years later. Participants will give blood, stool, and urine …
Sponsor: Umeå University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New tool helps colon polyp patients make tough treatment choices
Knowledge-focused Not yet recruitingThis study looks at whether a special decision aid helps patients with a cancerous colon polyp choose between more surgery or careful monitoring. About 110 adults in Denmark will use the aid during their doctor visit. The goal is to see if it changes treatment choices and improve…
Phase: PHASE2 • Sponsor: Vejle Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
Scientists probe gut bacteria after fecal transplants to unlock secrets of chronic disease
Knowledge-focused Not yet recruitingThis study will give fecal transplants to 90 people with recurrent C. difficile infection, ulcerative colitis, or metabolic syndrome. Researchers will use advanced tests on stool and tissue samples to track how donor bacteria settle in the gut and interact with the host. The goal…
Phase: NA • Sponsor: Catholic University of the Sacred Heart • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Magnetic endoscope could make colonoscopy easier for IBD patients
Knowledge-focused Not yet recruitingThis study will test a new type of colonoscope called the Magnetic Flexible Endoscope (MFE) in 6 people with inflammatory bowel disease (IBD). The MFE uses a magnet at its tip, moved by an external robotic arm, to gently travel through the colon. The goal is to see if it can reac…
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
AI and dye join forces to spot leaky gut in IBD patients
Knowledge-focused Not yet recruitingThis study tests a new imaging system that uses a fluorescent dye and artificial intelligence during colonoscopy to measure how leaky the gut lining is in people with inflammatory bowel disease (IBD). It includes 70 adults (60 with IBD and 10 without) at three Canadian hospitals.…
Sponsor: Hamilton Health Sciences Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Can naturopathic doctors help ease ulcerative colitis? new study aims to find out
Knowledge-focused Not yet recruitingThis study follows 50 adults with ulcerative colitis who are already seeing a naturopathic doctor. Over 12 weeks, researchers track symptom changes using questionnaires. The goal is to gather early information on how naturopathic care may help, without changing anyone's usual tre…
Sponsor: National University of Natural Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
New study maps colitis types in patients with chronic diarrhea and abdominal pain
Knowledge-focused Not yet recruitingThis study will examine 100 patients with lower gut symptoms like chronic diarrhea, blood in stool, or abdominal pain who are having a colonoscopy. Researchers want to see which types of colon inflammation (colitis) are most common and how they appear during the procedure. The go…
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Could stress make IBD treatments stop working?
Knowledge-focused Not yet recruitingThis study looks at how anxiety, depression, and stress might cause advanced IBD treatments to stop working. Researchers will ask 450 people with IBD to fill out questionnaires about their mental health while they receive regular infusions. The goal is to understand if mental hea…
Sponsor: The Royal Wolverhampton Hospitals NHS Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Could your gut bacteria predict colon Cancer's return?
Knowledge-focused Not yet recruitingThis study looks at whether certain bacteria in your stool can help predict if colon cancer will come back after surgery. Researchers will collect stool and blood samples from 107 adults before and after their surgery. They want to see if bacteria that break down collagen are lin…
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
New scale aims to help IBD patients manage their own care
Knowledge-focused Not yet recruitingThis study is building a new questionnaire to measure how well people with inflammatory bowel disease (IBD) take care of themselves. Researchers will talk to 275 adults with Crohn's disease or ulcerative colitis to understand their self-care habits, then test the questionnaire to…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
New Dye-Free colonoscopy could make cancer screening easier for IBD patients
Knowledge-focused Not yet recruitingPeople with inflammatory bowel disease (IBD) have a higher risk of colon cancer and need regular colonoscopies. This study compares two advanced methods: one uses a dye spray to highlight abnormal areas, and the other uses built-in camera filters to enhance the view without dye. …
Phase: NA • Sponsor: Region Stockholm • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
New study aims to predict who benefits from abdominal cancer surgery
Knowledge-focused Not yet recruitingThis study looks at how colorectal cancer grows when it spreads to the lining of the abdomen. Researchers want to see if the pattern of tumor growth can help doctors decide who will benefit most from surgery. The study will follow 30 adults who are already scheduled for surgery o…
Sponsor: Jules Bordet Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Fish oil before surgery may cut complications for constipation patients
Knowledge-focused Not yet recruitingThis study looks at whether giving fish oil nutrition before colon surgery helps patients with constipation recover better. About 306 adults will either get fish oil before surgery or only after. Researchers will compare complication rates, recovery, and quality of life. The goal…
Sponsor: Qianfoshan Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Massive saudi study aims to improve emergency surgery survival
Knowledge-focused Not yet recruitingThis study will collect data from 10,000 patients across Saudi Arabia who undergo emergency abdominal surgery (laparotomy). Researchers will track complications and deaths within 30 and 90 days after surgery. The goal is to understand current care quality, test international risk…
Sponsor: King Faisal Specialist Hospital & Research Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
New program aims to guide young cancer survivors through Follow-Up care
Knowledge-focused Not yet recruitingThis study is for young adults (ages 21-45) who had certain cancers as teens or young adults. Researchers are adapting a program that helps survivors manage their health after cancer treatment. The goal is to see if this program improves survivors' confidence and ability to handl…
Phase: NA • Sponsor: Kaiser Permanente • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Can lower chemo doses help older cancer patients?
Knowledge-focused Not yet recruitingThis study looks at medical records of 51 patients aged 70 and older with metastatic colorectal cancer. Researchers want to see if using lower doses of chemotherapy along with full-dose targeted therapy can reduce serious side effects like low white blood cell counts and severe d…
Sponsor: Matteo Clavarezza • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Simple blood test may forecast IBD severity
Knowledge-focused Not yet recruitingThis study will follow 83 adults with inflammatory bowel disease (IBD) at Assiut University Hospitals in Egypt to see if anemia can predict worse outcomes like hospitalizations. Anemia is common in IBD, but its role as a predictor is not well studied in this population. Researche…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
New probe aims to sharpen colonoscopy images
Knowledge-focused Not yet recruitingThis study tests a new device that takes detailed images of the lower gut during a standard colonoscopy. About 250 adults aged 45 to 75 will have the probe used during their procedure. The goal is to see if the device works well for real-time imaging.
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC
-
Could cancer antibodies trigger heart problems? new study investigates
Knowledge-focused Not yet recruitingThis study will check if people with metastatic breast or colon cancer have antibodies that might also attack the heart. Researchers will collect blood samples and ECGs from 196 participants over 12 months. The goal is to see if these antibodies raise the risk of dangerous heart …
Phase: NA • Sponsor: IRCCS Policlinico S. Donato • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Could ultrasound replace scopes for colitis checks?
Knowledge-focused Not yet recruitingThis pilot study will test whether a modified ultrasound technique can accurately measure disease activity in people with moderate-to-severe ulcerative colitis. Researchers will compare ultrasound results with standard colonoscopy findings in 25 patients starting a new treatment.…
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Keyhole surgery vs open surgery for colon cancer: which is better?
Knowledge-focused Not yet recruitingThis study compares two types of surgery for right-sided colon cancer: laparoscopic (keyhole) surgery and open surgery. The goal is to see which approach leads to less blood loss, fewer complications, and a shorter hospital stay. The study will include 22 adults with right colon …
Phase: NA • Sponsor: Kafrelsheikh University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Glow-in-the-Dark dyes reveal if IBD drugs hit their target
Knowledge-focused Not yet recruitingThis study tests whether fluorescent dyes attached to two IBD drugs (adalimumab and risankizumab) can show where the drugs go in the gut. 30 adults with ulcerative colitis or Crohn's disease will receive a low dose of the labelled drugs, then undergo a special camera procedure 2-…
Phase: PHASE1, PHASE2 • Sponsor: University Medical Center Groningen • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Can an ultrasound replace a colonoscopy for UC patients?
Knowledge-focused Not yet recruitingThis study looks at whether a simple intestinal ultrasound can accurately measure disease activity in people with active ulcerative colitis, compared to the standard colonoscopy. Researchers will enroll 200 adults with active UC to see if the ultrasound scores match the colonosco…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
Belly fat may hold key to ulcerative colitis treatment success
Knowledge-focused Not yet recruitingThis study looks at whether measuring visceral fat (belly fat) using CT scans can predict how well ulcerative colitis patients respond to biologic therapy. Researchers will follow 200 adults with active ulcerative colitis for 6 months, tracking changes in fat volume and treatment…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
AI eye in the colon: new study aims to catch hidden polyps
Knowledge-focused Not yet recruitingThis study tests whether a computer-aided detection system can help doctors find more polyps in the right side of the colon during a colonoscopy. About 686 adults aged 40-75 will have two colonoscopies in one session, with the AI system used in one of them. The goal is to see if …
Phase: NA • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Gut bacteria clues: h. pylori and IBD under the microscope
Knowledge-focused Not yet recruitingThis study will check how common Helicobacter pylori infection is in 100 adults with inflammatory bowel disease (Crohn's or colitis) at the Guadeloupe hospital. Researchers will take extra stomach biopsies during routine endoscopy to study the stomach's bacteria. The goal is to s…
Sponsor: Centre Hospitalier Universitaire de la Guadeloupe • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Exercise study aims to unlock biological secrets in cancer care
Knowledge-focused Not yet recruitingThis study looks at how a personalized strength training program affects people with different cancers, including lung, colon, breast, and blood cancers. 150 adults will either do supervised strength training plus home exercises, or just home exercises, for 12 weeks. Researchers …
Phase: NA • Sponsor: University of Salamanca • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Could low vitamin d worsen IBD? new study investigates
Knowledge-focused Not yet recruitingThis study will measure vitamin D levels in 100 adults with inflammatory bowel disease (Crohn's or ulcerative colitis) to see if low vitamin D is linked to more active disease. Participants will have blood tests for vitamin D and inflammation markers. The goal is to better unders…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Scientists hunt for friendly viruses to tame IBD
Knowledge-focused Not yet recruitingThis study looks at the viruses (called bacteriophages) living in the guts of people with inflammatory bowel disease (IBD) and healthy people. Researchers want to understand how these viruses differ and whether they can be grown in a lab to create a new treatment. The study invol…
Sponsor: Andreas Munk Petersen • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Simple Pre-Surgery steps could boost stoma Patients' quality of life
Knowledge-focused Not yet recruitingThis study will follow 100 people who need a stoma (an opening in the belly to pass stool) after surgery. Some will have their stoma site marked and get education before surgery, while others will not. The goal is to see if these steps improve quality of life and reduce problems …
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
New study investigates stomach problems after colon cancer surgery
Knowledge-focused Not yet recruitingThis study looks at why some people have ongoing loose stools after surgery for colon cancer. Researchers will use a new device to check for bile acid problems and bacterial overgrowth in the small intestine. The goal is to better understand these symptoms and how they affect qua…
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
New imaging tech could spot colon cancer early in IBD patients
Knowledge-focused Not yet recruitingThis study compares a newer imaging method called TXI with standard dye-based imaging during colonoscopies in people with inflammatory bowel disease (IBD). The goal is to see which method better detects precancerous changes that can lead to bowel cancer. About 242 adults with IBD…
Phase: NA • Sponsor: London North West Healthcare NHS Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Hidden inflammation uncovered: ultrasound could spot joint issues in IBD patients before symptoms appear
Knowledge-focused Not yet recruitingThis study will use musculoskeletal ultrasound to look for hidden joint, muscle, and tendon inflammation in 81 people with inflammatory bowel disease (IBD) who have no known arthritis. The goal is to see how common these hidden problems are and to develop a standard ultrasound ch…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
New registry aims to decode mysterious immune side effects of cancer drugs
Knowledge-focused Not yet recruitingThis study creates a registry of 500 cancer patients receiving immunotherapy to better understand and manage immune-related side effects (irAEs). Researchers will collect data on who gets these side effects, how they present, and what treatments work best. The goal is to improve …
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Robots to the rescue: can they handle emergency surgery?
Knowledge-focused Not yet recruitingThis study will test whether robotic surgery can be used for emergency abdominal operations, such as for severe gallbladder infections or bowel blockages. The goal is to see if it's feasible and if it can lower complication rates and shorten hospital stays compared to traditional…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Vitamin d study aims to boost quality of life for IBD patients
Knowledge-focused Not yet recruitingThis study looks at whether taking a daily vitamin D supplement (2000 IU) for 12 months can improve the health and quality of life of people with Crohn's disease or ulcerative colitis. Researchers will track how well participants stick to the supplement and measure their vitamin …
Phase: PHASE1 • Sponsor: Terry Ponich • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:13 UTC
-
4500 IBD patients enrolled in quest for early warning biomarkers
Knowledge-focused Not yet recruitingThis observational study will follow 4500 adults with Crohn's disease or ulcerative colitis to identify biological markers—such as gut bacteria patterns—that predict disease progression and complications. Researchers will collect blood, stool, saliva, and tissue samples during ro…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:06 UTC
-
Your watch and grocery list could spot IBD flares early
Knowledge-focused Not yet recruitingThis study tests whether data from a wearable device and grocery loyalty cards can help detect disease flares in people with Crohn's disease or ulcerative colitis. Eighty adults will wear a smartwatch and use a store card to track their health and food purchases. The goal is to d…
Sponsor: Imelda GI Clinical Research Center • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:37 UTC
-
New study aims to pinpoint Cancer's hidden path in colon surgery
Knowledge-focused Not yet recruitingThis observational study will examine lymph nodes from the ileum mesentery in 406 people undergoing surgery for right-sided colon cancer. Researchers want to learn where cancer spreads in these nodes to help surgeons decide how much tissue to remove. Participants will be followed…
Sponsor: Peking Union Medical College Hospital • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:20 UTC
-
Computer model aims to optimize infliximab shots for IBD patients
Knowledge-focused Not yet recruitingThis study uses computer simulations to better understand how a subcutaneous (under-the-skin) form of the drug infliximab works in people with inflammatory bowel disease (IBD) and rheumatoid arthritis. Researchers will analyze data from previous trials to create a model that pred…
Sponsor: Erwin Dreesen • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:17 UTC
-
New study to track hidden salt and mineral imbalances in sick kids
Knowledge-focused Not yet recruitingThis study will look at 150 infants and children aged 1 month to 4 years who are admitted to a hospital gastroenterology unit with a gastrointestinal disease. The goal is to find out how common electrolyte disturbances (like low sodium or potassium) are in these children. By meas…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 26, 2026 12:41 UTC